Evidence map›Paper›PMID 20331855›Full record

ArticleRetrovirology2010

Cysteine 95 and other residues influence the regulatory effects of Histidine 69 mutations on Human Immunodeficiency Virus Type 1 protease autoprocessing.

Liangqun Huang, Alyssa Hall, Chaoping Chen

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Liangqun HuangDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, USA.
Alyssa Hall
Chaoping Chen
Colorado State University · US

Funding

Isolation and Characterization of Aptamers Targeted to Inhibit HIV Protease MaturR21AI080351 · NIAID · COLORADO STATE UNIVERSITY · PI CHEN, CHAOPING · 2009 to 2010
$400k
NIAID NIH HHS R21 AI080351PHS HHS R21A1080351
6 · The paper itself

Abstract

backgroundRegulated autoprocessing of HIV Gag-Pol precursor is required for the production of mature and fully active protease. We previously reported that H69E mutation in a pseudo wild type protease sequence significantly (>20-fold) impedes protease maturation in an in vitro autoprocessing assay and in transfected mammalian cells.

resultsInterestingly, H69E mutation in the context of a laboratory adapted NL4-3 protease showed only moderate inhibition (approximately 4-fold) on protease maturation. There are six point mutations (Q7K, L33I, N37S, L63I, C67A, and C95A) between the NL4-3 and the pseudo wild type proteases suggesting that the H69E effect is influenced by other residues. Mutagenesis analyses identified C95 as the primary determinant that dampened the inhibitory effect of H69E. L63 and C67 also demonstrated rescue effect to a less extent. However, the rescue was completely abolished when H69 was replaced by aspartic acid in the NL4-3 backbone. Charge substitutions of surface residues (E21, D30, E34, E35, and F99) to neutral or positively charged amino acids failed to restore protease autoprocessing in the context of H69E mutation.

conclusionsTaken together, we suggest that residue 69 along with other amino acids such as C95 plus L63 and C67 to a less extent modulate precursor structures for the regulation of protease autoprocessing in the infected cell.

Indexed as

Gene Expression Regulation, ViralMutation, MissenseAmino Acid SubstitutionCell Linegag Gene Products, Human Immunodeficiency VirusHIV-1HIV ProteaseHumansMutagenesis, Site-Directedpol Gene Products, Human Immunodeficiency VirusProtein Processing, Post-Translationalgag Gene Products, Human Immunodeficiency VirusHIV Proteasep16 protease, Human immunodeficiency virus 1pol Gene Products, Human Immunodeficiency Virus

Identifiers

PMID20331855
PMCPMC2850873
OpenAlexW2095719962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.